Drug Profile


Alternative Names: BASF 52404; RWJ 24834

Latest Information Update: 29 Jan 2013

Price : $50

At a glance

  • Originator Abbott Laboratories; Ortho-McNeil
  • Developer Ortho-McNeil
  • Class Hydrazones; Small molecules
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Skin disorders

Most Recent Events

  • 20 Feb 1997 Discontinued - Preclinical for Skin disorders in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top